Health ❯Medications

Weight Loss Drugs

Ozempic GLP-1 Agonists Wegovy GLP-1 Drugs Semaglutide GLP-1 Receptor Agonists Side Effects GLP-1 Mounjaro Zepbound Tirzepatide Effects on Senses GLP-1s GLP-1 Medications GLP-1 Receptor Antagonists

Half of Danish Semaglutide Users Quit Within a Year, Registry Study Finds

Researchers warn benefits require ongoing therapy, with price pressures or side effects often derailing persistence.

Novo Nordisk to Cut 9,000 Jobs, Lowers Profit Outlook in Global Restructuring

DVLA Refuses to Renew Christopher Biggins’ Licence After Eyesight Assessment

Researchers Call for Trials to Assess Ozempic’s Impact on Muscle Health

GLP-1 Weight-Loss Drugs Fail to Boost Fitness and Cause Significant Muscle Loss

Katie Price’s Son Harvey to Begin Mounjaro Treatment Ahead of Southampton Move

Ozempic and Wegovy Users Face Dental Decay and Unusual Scent Cravings

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Sophia Umansky Reveals Severe Hair Loss Linked to Weight-Loss Drug Mounjaro

Karan Johar Refutes Ozempic Rumors, Shares Weight Loss Journey

Widespread Use of Weight-Loss Drugs Redefines Health, Beauty, and Access

Megan Stalter Criticizes Ozempic Use for Weight Loss

GLP-1 Weight Loss Drugs Surge in Popularity Amidst Stigma and Cultural Shifts

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

Super Bowl Ad for Compounded Weight Loss Drugs Draws Criticism Over Safety and Regulation

Navigating Thanksgiving on Weight-Loss Drugs: Expert Advice on Food Choices

FDA Declares End to Tirzepatide Shortage, Impacting Compounded Drug Market

James Corden Reveals Ozempic Failed to Address His Food Addiction

Tory Leadership Contender Robert Jenrick Discusses Weight Loss Journey

Ozempic's Expanding Role: Beyond Diabetes and Weight Loss